Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q82872506 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241120235926.0 | ||
| 008 | 241120nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q82872506 | ||
| 024 | ‡a 0000-0002-3515-0215 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q82872506 | ||
| 100 | 0 | ‡a Mary Ann Anderson ‡c researcher ‡9 en | |
| 375 | ‡a 2 ‡2 iso5218 | ||
| 400 | 0 | ‡a M A Anderson ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia | ||
| 670 | ‡a Author's BCL2 inhibition in double hit lymphoma. | ||
| 670 | ‡a Author's BH3 mimetic therapy: an emerging and promising approach to treating chronic lymphocytic leukemia. | ||
| 670 | ‡a Author's Both leukaemic and normal peripheral B lymphoid cells are highly sensitive to the selective pharmacological inhibition of prosurvival Bcl-2 with ABT-199. | ||
| 670 | ‡a Author's Charcot-Leyden crystals | ||
| 670 | ‡a Author's Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax. | ||
| 670 | ‡a Author's Current challenges and novel treatment strategies in double hit lymphomas | ||
| 670 | ‡a Author's Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma | ||
| 670 | ‡a Author's Persistent complement-dependent anti-AnWj in a lymphoproliferative disorder: a case study and review. | ||
| 670 | ‡a Author's Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations | ||
| 670 | ‡a Author's Targeting BCL2 for the treatment of lymphoid malignancies | ||
| 670 | ‡a Author's The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism. | ||
| 670 | ‡a Author's Transformed Lymphoma. | ||
| 670 | ‡a Author's Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study | ||
| 670 | ‡a Author's Venous thromboembolism management practices and knowledge of guidelines: a survey of Australian haematologists and respiratory physicians | ||
| 909 | ‡a (orcid) 0000000235150215 ‡9 1 | ||
| 919 | ‡a bh3mimetictherapyanemergingandpromisingapproachtotreatingchroniclymphocyticleukemia ‡A BH3 mimetic therapy: an emerging and promising approach to treating chronic lymphocytic leukemia. ‡9 1 | ||
| 919 | ‡a charcotleydencrystals ‡A Charcot-Leyden crystals ‡9 1 | ||
| 919 | ‡a clinicopathologicalfeaturesandoutcomesofprogressionofcllonthebcl2inhibitorvenetoclax ‡A Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax. ‡9 1 | ||
| 919 | ‡a currentchallengesandnoveltreatmentstrategiesindoublehitlymphomas ‡A Current challenges and novel treatment strategies in double hit lymphomas ‡9 1 | ||
| 919 | ‡a dynamicmolecularmonitoringrevealsthatswisnfmutationsmediateresistancetoibrutinibplusvenetoclaxinmantlecelllymphoma ‡A Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma ‡9 1 | ||
| 919 | ‡a persistentcomplementdependentantianwjinalymphoproliferativedisorderacasestudyandreview ‡A Persistent complement-dependent anti-AnWj in a lymphoproliferative disorder: a case study and review. ‡9 1 | ||
| 919 | ‡a structuresofbcl2incomplexwithvenetoclaxrevealthemolecularbasisofresistancemutations ‡A Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations ‡9 1 | ||
| 919 | ‡a targetingbcl2forthetreatmentoflymphoidmalignancies ‡A Targeting BCL2 for the treatment of lymphoid malignancies ‡9 1 | ||
| 919 | ‡a bcl2selectiveinhibitorvenetoclaxinducesrapidonsetapoptosisofcllcellsinpatientsviaatp53independentmechanism ‡A The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism. ‡9 1 | ||
| 919 | ‡a transformedlymphoma ‡A Transformed Lymphoma. ‡9 1 | ||
| 919 | ‡a venetoclaxplusrituximabinrelapsedorrefractorychroniclymphocyticleukaemiaaphase1bstudy ‡A Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study ‡9 1 | ||
| 919 | ‡a venousthromboembolismmanagementpracticesandknowledgeofguidelinesasurveyofaustralianhaematologistsandrespiratoryphysicians ‡A Venous thromboembolism management practices and knowledge of guidelines: a survey of Australian haematologists and respiratory physicians ‡9 1 | ||
| 919 | ‡a bothleukaemicandnormalperipheralblymphoidcellsarehighlysensitivetotheselectivepharmacologicalinhibitionofprosurvivalbcl2withabt199 ‡A Both leukaemic and normal peripheral B lymphoid cells are highly sensitive to the selective pharmacological inhibition of prosurvival Bcl-2 with ABT-199. ‡9 1 | ||
| 919 | ‡a acquisitionoftherecurrentgly101valmutationinbcl2confersresistancetovenetoclaxinpatientswithprogressivechroniclymphocyticleukemia ‡A Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia ‡9 1 | ||
| 919 | ‡a bcl2inhibitionindoublehitlymphoma ‡A BCL2 inhibition in double hit lymphoma. ‡9 1 | ||
| 946 | ‡a a ‡9 1 | ||
| 996 | ‡2 LC|n 98029561 | ||
| 996 | ‡2 SUDOC|147391067 | ||
| 996 | ‡2 BNF|12293879 | ||
| 996 | ‡2 LC|n 2024020573 | ||
| 996 | ‡2 LC|no 92024184 | ||
| 996 | ‡2 BIBSYS|90860988 | ||
| 996 | ‡2 ISNI|0000000062207083 | ||
| 996 | ‡2 LC|n 88152936 | ||
| 996 | ‡2 SUDOC|171404483 | ||
| 996 | ‡2 PLWABN|9810700716505606 | ||
| 996 | ‡2 LC|n 78046972 | ||
| 996 | ‡2 BIBSYS|1542227325319 | ||
| 996 | ‡2 NLA|000035728068 | ||
| 996 | ‡2 LC|no2012010427 | ||
| 996 | ‡2 LC|n 88083995 | ||
| 996 | ‡2 RERO|A002928404 | ||
| 996 | ‡2 RERO|A002928405 | ||
| 996 | ‡2 RERO|A002928406 | ||
| 996 | ‡2 CAOONL|ncf10224933 | ||
| 996 | ‡2 LC|n 82247888 | ||
| 996 | ‡2 ISNI|0000000043513456 | ||
| 996 | ‡2 SUDOC|07588612X | ||
| 996 | ‡2 ISNI|0000000082278225 | ||
| 996 | ‡2 LC|n 96033529 | ||
| 996 | ‡2 PLWABN|9810699369305606 | ||
| 996 | ‡2 ISNI|0000000063448751 | ||
| 996 | ‡2 LC|nb2011027358 | ||
| 996 | ‡2 DNB|1130252205 | ||
| 996 | ‡2 ISNI|0000000500661965 | ||
| 996 | ‡2 DNB|1337582328 | ||
| 996 | ‡2 ISNI|000000043729310X | ||
| 996 | ‡2 ISNI|0000000395985983 | ||
| 996 | ‡2 LC|n 93044424 | ||
| 996 | ‡2 NDL|01046714 | ||
| 996 | ‡2 LC|n 87127375 | ||
| 996 | ‡2 PLWABN|9810683184805606 | ||
| 996 | ‡2 DBC|87097968066662 | ||
| 996 | ‡2 CAOONL|ncf10586852 | ||
| 996 | ‡2 LC|no 93013897 | ||
| 996 | ‡2 CAOONL|ncf10514378 | ||
| 996 | ‡2 LC|n 88669421 | ||
| 996 | ‡2 NII|DA17666871 | ||
| 996 | ‡2 DNB|11630667X | ||
| 996 | ‡2 ISNI|0000000062873254 | ||
| 996 | ‡2 SUDOC|256196303 | ||
| 996 | ‡2 ISNI|0000000063019471 | ||
| 996 | ‡2 ISNI|0000000079028487 | ||
| 996 | ‡2 CAOONL|ncf10311101 | ||
| 996 | ‡2 LIH|LNB:V-63127;=BF | ||
| 996 | ‡2 DNB|14262912X | ||
| 996 | ‡2 LC|n 85821867 | ||
| 996 | ‡2 ISNI|0000000078953224 | ||
| 996 | ‡2 LC|n 87916392 | ||
| 996 | ‡2 BIBSYS|90655051 | ||
| 996 | ‡2 NLA|000035810175 | ||
| 996 | ‡2 LC|no2010077647 | ||
| 996 | ‡2 LC|nr 00020143 | ||
| 996 | ‡2 SUDOC|03332803X | ||
| 996 | ‡2 LC|no2003125272 | ||
| 996 | ‡2 DNB|1157357318 | ||
| 996 | ‡2 J9U|987007427082105171 | ||
| 996 | ‡2 DNB|1055470697 | ||
| 996 | ‡2 W2Z|8008754 | ||
| 996 | ‡2 ISNI|0000000367108916 | ||
| 996 | ‡2 LC|n 2008000149 | ||
| 996 | ‡2 ISNI|0000000025521380 | ||
| 996 | ‡2 SELIBR|296832 | ||
| 996 | ‡2 SELIBR|296831 | ||
| 996 | ‡2 ISNI|0000000356588555 | ||
| 996 | ‡2 J9U|987007421569505171 | ||
| 996 | ‡2 NTA|37059455X | ||
| 996 | ‡2 NLA|000035658674 | ||
| 996 | ‡2 ISNI|0000000045077459 | ||
| 996 | ‡2 BIBSYS|90645263 | ||
| 996 | ‡2 ISNI|0000000084656330 | ||
| 996 | ‡2 ISNI|0000000507257017 | ||
| 996 | ‡2 NUKAT|n 2017018595 | ||
| 996 | ‡2 DNB|1111006954 | ||
| 996 | ‡2 SUDOC|114655650 | ||
| 996 | ‡2 DNB|142272299 | ||
| 996 | ‡2 BAV|495_85970 | ||
| 996 | ‡2 NII|DA03666658 | ||
| 996 | ‡2 NTA|067935664 | ||
| 996 | ‡2 LC|n 97041675 | ||
| 996 | ‡2 ISNI|0000000024145248 | ||
| 996 | ‡2 LC|no 99067504 | ||
| 996 | ‡2 LC|no2018015284 | ||
| 996 | ‡2 LC|n 86079114 | ||
| 996 | ‡2 JPG|500339538 | ||
| 996 | ‡2 BNC|981058518794506706 | ||
| 996 | ‡2 LC|n 87128240 | ||
| 996 | ‡2 DBC|87097968066670 | ||
| 996 | ‡2 NDL|00431470 | ||
| 996 | ‡2 SUDOC|158283821 | ||
| 996 | ‡2 LC|n 2006211406 | ||
| 996 | ‡2 LC|n 97062396 | ||
| 996 | ‡2 ISNI|0000000116326476 | ||
| 996 | ‡2 LC|n 83020737 | ||
| 996 | ‡2 BIBSYS|11028384 | ||
| 996 | ‡2 DNB|1196236321 | ||
| 996 | ‡2 CAOONL|ncf10124244 | ||
| 996 | ‡2 BIBSYS|1037841 | ||
| 996 | ‡2 LC|n 77012914 | ||
| 996 | ‡2 NUKAT|n 2019163316 | ||
| 996 | ‡2 LC|n 96096718 | ||
| 996 | ‡2 DNB|108916310X | ||
| 996 | ‡2 NII|DA13724808 | ||
| 996 | ‡2 SUDOC|119057808 | ||
| 996 | ‡2 SUDOC|262559846 | ||
| 996 | ‡2 NTA|069241791 | ||
| 996 | ‡2 NUKAT|n 01044064 | ||
| 996 | ‡2 LC|no2021149721 | ||
| 996 | ‡2 BIBSYS|7043179 | ||
| 996 | ‡2 LC|no2011073198 | ||
| 996 | ‡2 LC|n 89670100 | ||
| 996 | ‡2 UIY|000000628 | ||
| 996 | ‡2 NII|DA02371397 | ||
| 996 | ‡2 ISNI|0000000053727730 | ||
| 996 | ‡2 ISNI|0000000045002342 | ||
| 996 | ‡2 ISNI|0000000032398288 | ||
| 996 | ‡2 ISNI|0000000498997709 | ||
| 996 | ‡2 J9U|987007328454005171 | ||
| 996 | ‡2 ISNI|0000000000446871 | ||
| 996 | ‡2 CAOONL|ncf11235831 | ||
| 996 | ‡2 LC|n 2020062876 | ||
| 996 | ‡2 N6I|vtls000374462 | ||
| 996 | ‡2 DNB|12273694X | ||
| 996 | ‡2 NLA|000035006593 | ||
| 996 | ‡2 RERO|A006182974 | ||
| 996 | ‡2 NDL|00431471 | ||
| 996 | ‡2 LC|n 81092873 | ||
| 996 | ‡2 LC|no2019124605 | ||
| 996 | ‡2 LC|n 78065452 | ||
| 996 | ‡2 LC|n 90653113 | ||
| 996 | ‡2 BIBSYS|90400011 | ||
| 996 | ‡2 LC|n 82066602 | ||
| 996 | ‡2 DNB|1247034321 | ||
| 996 | ‡2 LC|no2022074997 | ||
| 996 | ‡2 CAOONL|ncf10256223 | ||
| 996 | ‡2 LC|n 98015291 | ||
| 996 | ‡2 LC|n 92112192 | ||
| 996 | ‡2 DNB|122910400 | ||
| 996 | ‡2 NLA|000035597710 | ||
| 996 | ‡2 DNB|121663973 | ||
| 996 | ‡2 LC|nb2021000235 | ||
| 996 | ‡2 RERO|A002928431 | ||
| 996 | ‡2 RERO|A002928432 | ||
| 996 | ‡2 BNF|15114648 | ||
| 996 | ‡2 NKC|mub2015861736 | ||
| 996 | ‡2 BIBSYS|8008754 | ||
| 996 | ‡2 NTA|300382529 | ||
| 996 | ‡2 ISNI|0000000117761699 | ||
| 996 | ‡2 DNB|1044882492 | ||
| 996 | ‡2 LC|n 2013003456 | ||
| 996 | ‡2 LC|nb2020007481 | ||
| 996 | ‡2 NTA|170680150 | ||
| 996 | ‡2 NUKAT|n 2013010059 | ||
| 996 | ‡2 LC|no2011113627 | ||
| 996 | ‡2 ISNI|0000000073964485 | ||
| 996 | ‡2 SUDOC|191385913 | ||
| 996 | ‡2 NLA|000035006591 | ||
| 996 | ‡2 RERO|A023337173 | ||
| 996 | ‡2 NII|DA03262921 | ||
| 996 | ‡2 LC|n 50021936 | ||
| 996 | ‡2 LC|n 50021935 | ||
| 996 | ‡2 BIBSYS|90172817 | ||
| 996 | ‡2 CAOONL|ncf10464127 | ||
| 996 | ‡2 NII|DA05312270 | ||
| 996 | ‡2 LC|n 2013039340 | ||
| 996 | ‡2 SUDOC|069788421 | ||
| 996 | ‡2 LC|nb2013016342 | ||
| 996 | ‡2 LC|n 88259989 | ||
| 996 | ‡2 ISNI|0000000076528152 | ||
| 996 | ‡2 SELIBR|377725 | ||
| 996 | ‡2 LC|no 90021463 | ||
| 996 | ‡2 BNF|15712822 | ||
| 996 | ‡2 SELIBR|235326 | ||
| 996 | ‡2 NUKAT|n 2004006264 | ||
| 996 | ‡2 NUKAT|n 95303309 | ||
| 996 | ‡2 BNF|12420487 | ||
| 996 | ‡2 ISNI|0000000497417506 | ||
| 996 | ‡2 CAOONL|ncf10380463 | ||
| 996 | ‡2 J9U|987007324496405171 | ||
| 996 | ‡2 ISNI|0000000416196087 | ||
| 996 | ‡2 SUDOC|08891108X | ||
| 996 | ‡2 LC|n 90682092 | ||
| 996 | ‡2 J9U|987007341523605171 | ||
| 996 | ‡2 J9U|987007442247205171 | ||
| 996 | ‡2 PLWABN|9810670253905606 | ||
| 996 | ‡2 SELIBR|296826 | ||
| 996 | ‡2 ISNI|0000000069101951 | ||
| 996 | ‡2 ISNI|0000000035243986 | ||
| 996 | ‡2 ISNI|0000000034730467 | ||
| 996 | ‡2 NSK|000133288 | ||
| 996 | ‡2 LC|n 87129276 | ||
| 996 | ‡2 ISNI|0000000040365937 | ||
| 996 | ‡2 BAV|495_85969 | ||
| 996 | ‡2 ISNI|0000000037080244 | ||
| 996 | ‡2 ISNI|0000000361881377 | ||
| 996 | ‡2 ISNI|0000000040565672 | ||
| 996 | ‡2 SUDOC|075186217 | ||
| 996 | ‡2 DNB|1157919960 | ||
| 996 | ‡2 ISNI|0000000120454083 | ||
| 996 | ‡2 LC|no2018092937 | ||
| 996 | ‡2 CAOONL|ncf10092740 | ||
| 996 | ‡2 LC|n 88656856 | ||
| 996 | ‡2 NII|DA08439868 | ||
| 996 | ‡2 N6I|vtls000331326 | ||
| 996 | ‡2 J9U|987007318198505171 | ||
| 996 | ‡2 LC|nr 96015013 | ||
| 996 | ‡2 ISNI|0000000034233276 | ||
| 996 | ‡2 BIBSYS|90503646 | ||
| 996 | ‡2 SUDOC|266777082 | ||
| 996 | ‡2 LC|no2011088047 | ||
| 996 | ‡2 SELIBR|q20m57qgnh5hwc84 | ||
| 996 | ‡2 BNF|12971738 | ||
| 996 | ‡2 ISNI|000000049944847X | ||
| 996 | ‡2 NTA|241647967 | ||
| 996 | ‡2 ISNI|0000000496099243 | ||
| 996 | ‡2 LC|nr2002041231 | ||
| 996 | ‡2 LC|n 90666361 | ||
| 996 | ‡2 ISNI|0000000081631736 | ||
| 996 | ‡2 ISNI|0000000031585671 | ||
| 996 | ‡2 LC|n 2021065241 | ||
| 996 | ‡2 RERO|A012903271 | ||
| 996 | ‡2 NII|DA05366451 | ||
| 996 | ‡2 J9U|987012358275405171 | ||
| 996 | ‡2 LC|n 98084896 | ||
| 996 | ‡2 NSK|000124536 | ||
| 996 | ‡2 LC|no2020048817 | ||
| 996 | ‡2 ISNI|000000004186034X | ||
| 996 | ‡2 LC|no2005085673 | ||
| 996 | ‡2 J9U|987007350612705171 | ||
| 996 | ‡2 NII|DA0610266X | ||
| 996 | ‡2 ISNI|0000000037118716 | ||
| 996 | ‡2 LC|n 2005088569 | ||
| 996 | ‡2 ISNI|0000000108974430 | ||
| 996 | ‡2 J9U|987007463244605171 | ||
| 996 | ‡2 RERO|A011995436 | ||
| 996 | ‡2 N6I|vtls001209884 | ||
| 996 | ‡2 RERO|A016526452 | ||
| 996 | ‡2 ISNI|0000000033619521 | ||
| 996 | ‡2 B2Q|0000449293 | ||
| 996 | ‡2 ISNI|0000000048141364 | ||
| 996 | ‡2 LC|no2016043148 | ||
| 996 | ‡2 BIBSYS|11052964 | ||
| 996 | ‡2 LC|n 80086919 | ||
| 996 | ‡2 LC|n 95036791 | ||
| 996 | ‡2 ISNI|0000000063903187 | ||
| 996 | ‡2 CAOONL|ncf10270427 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
